Vascular Grafts Market (By Product: Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts; By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease; By Raw Material: Polyester, Polytetrafluoroethylene, Polyurethane, Biological Material Based; By End User: Hospitals, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030


The global vascular grafts market size was estimated at USD 5.37 billion in 2021 and it is expected to surpass around USD 8.5 billion by 2030, growing at a CAGR of 5.24% from 2022 to 2030.

Vascular Grafts Market Size 2021 to 2030

Currently synthetic vascular graft materials are used in order to patch the diseased area of the arteries. Vascular grafts can be used in arteries, capillaries or veins. There was a negative impact of the pandemic on vascular graft market as the supply chain distribution system and operations were all halted, there were cancellations or postpones in all of these procedures as the healthcare professionals across the globe are focusing on COVID-19 treatment and all the non essential surgeries were declined.

Growth Factors

The increase in the number of chronic kidney diseases and dialysis procedure has led to a growth in the market about a couple of million people take treatment for dialysis across the world so it happens to drive the market for vascular grafts. Increase in the cardiovascular diseases renal diseases and diabetes are driving the market for the vascular grafts. Across the world many deaths occur due to the cardiovascular diseases across many nations. Surgeries related to the heart involve the use of vascular grafts and hence the market is expected to grow during the forecast. The availability of reimbursement policies rising healthcare expenditure and increased demand for the technologically advanced products are offering great opportunities for the growth of this market the use of next generation tissue engineered vascular grafts is also driving the market across the globe. As there is an advancement in the surgical procedure related to the coronary artery the demand for vascular grafts is expected to grow in the coming years.

Report Scope of the Vascular Grafts Market

Report Coverage Details
Market Size by 2030 USD 8.5 Billion
Growth Rate from 2022 to 2030

CAGR of 5.24%

North America Market Share in 2021 31% 
Endovascular Stent Grafts Market Share in 2021 64%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Application, End User, Raw Material, Geography
Companies Mentioned Getinge AB, Medtronic PLC, LeMaitre vascular Inc, WL gore and associates, terumo corporation, Shanghai suokang medical implants Co limited, Cook medical

 

Product Insights

On the basis of the product, the endovascular stent grafts segment accounted market share of around 64% in 2021. There is an increased growth specially in the treatment of abdominal aortic aneurysm and the increase in these treatments has led to a growth in the market. Increasing demand for thoracic aortic aneurysms has led to the adoption of endovascular stent grafts and this should be a major factor which shall help in the growth of the market. Stent graphs along with the antibiotics can be used in the treatment of mycotic aneurysm. The developments in the endovascular applications will lead to a growth in the endovascular stent grafts market. There is a fast rate of recovery with the use of endovascular grafts also there is a reduction in the hospital stay. Endovascular grafts are less painful when they are compared with the open surgeries so, there is an increasing demand for surgeries across the world.

Peripheral vascular grafts segment is also expected to have a good growth during the forecast. Due to increasing rate of hardening of the arteries and the conditions of renal failure and in order to treat the peripheral artery disease many technical advancements are made and products are developed that would lead to an increase in the demand of this segment in the forecast period.

Application Insights

The cardiac aneurysm segment accounted largest revenue share of around 52% in 2021. As there is an increase in various conditions like high blood pressure rising cholesterol levels the sedentary life style and the growing geriatric population across the globe the cardiac aneurysm segment will grow during the forecast. This segment is expected to grow in the future as the congenital heart disease involves congenital heart surgeries which are carried out using the advanced tissue engineered grafts is in demand. As a result high rate of organ transplant failure there is an increase in the adoption of minimally invasive vascular implants for the surgical reconstruction of cardiovascular diseases.

The demand for cardiac aneurysm products shall grow during the forecast period owing to all of these reasons. As there is unavailability of using grafts in vascular activation disease the demand for vascular occlusion shall help in the growth of the market in this segment. The synthetic grafts which are used in the treatment of vascular occlusion shall help in the growth of the market during the forecast.

Raw Materials Insights

On the basis of the raw material, the polytetrafluoroethylene segment accounted revenue share of 47% in 2021. Polytetrafluoroethylene is used for peripheral bypass procedures as this material adequately interacts with the tissue and it is extremely easy to use. Various technological advancements or modifications in this raw material have also helped in the growth of the market segment.

Vascular Grafts Market Share, By Raw Material, 2021 (%)

Apart from the polytetrafluoroethylene segment the polyester segment is also expected to have a significant growth during the forecast. As this material is easily available and it is robust and durable the market is expected to see a growth. The use of polyester vascular grafts has Increased as there is a demand for vascular grafts with small diameters. Therefore this market segment is expected to grow well during the forecast.

Regional Insights

North America is the largest market share 31% in 2021 for vascular grafts estrogen increasing health awareness and great health care facilities available across the nations, availability of good health care facilities for the treatment of cardiovascular diseases in this region has helped in the growth of the market adoption of advanced technological procedures and the availability of reimbursement policies have led to the growth in the market. As there is an increase in the development and discoveries of the tissue engineered products which are used in surgeries the market is growing. Constant R&D for the development of biomaterial grafts is providing a great opportunity for the growth of this market. People fear cardiac disorders as there are premature deaths hence the market is expected to grow well during the forecast period.

Asia Pacific region is expected to witness strong growth over the forecast period 2022 to 2030.

Key market players at the vascular grafts market

  • Getinge AB
  • Medtronic PLC
  • LeMaitre vascular Inc
  • WL gore and associates
  • terumo corporation
  • Shanghai suokang medical implants Co limited
  • Cook medical

Recent Developments

  • In March 2021 a medical device received approval from the FDA which is the Zenith fenestrated endovascular graft. This product is expected to provide great revenue from its sales as it will be effective in the treatment and the diagnosis of debilitating diseases or conditions.
  • Terumo Aortic received approval for the Tero abdominal aortic stent grafts in October 2021. This Japanese device will be helped in the treatment for abdominal aortic aneurysms
  • The relay pro thoracic stent grafts system was also approved by FDA in August 2021 the terumo corporation will use this for the treatment of patients with a thoracic aortic aneurysms.
  • ArtegraftInc was acquired by LeMaitre vascular Inc in June 2020. This acquisition helped in gaining access to the ArtegraftInc’s portfolio of biological vascular grafts.

Segments covered in the report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Vascular Grafts for Aorta Disease
  • Peripheral Vascular Grafts
  • Endovascular Stent Grafts
  • Coronary Artery By-Pass Grafts

By Application

  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease

By Raw Material

  • Polyester Vascular Grafts
  • Polytetrafluoroethylene Vascular Grafts
  • Polyurethane Vascular Grafts
  • Biological Material Based Vascular Grafts
    • Human Saphenous and Umbilical Veins
    • Tissue Engineered Materials

By End User

  • Hospitals
  • Ambulatory Surgical Centers

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of vascular grafts market?
The global vascular grafts market size was reached at USD 5.37 billion in 2021 and it is expected to rake around USD 8.5 billion by 2030.
What will be the CAGR of global vascular grafts market?
The global vascular grafts market is expected to drive growth at a CAGR of 5.24% from 2022 to 2030.
Who are the major players operating in the vascular grafts market?
The major players operating in the vascular grafts market are Getinge AB, Medtronic PLC, LeMaitre vascular Inc, WL gore and associates, terumo corporation, Shanghai suokang medical implants Co limited, and Cook medical.
Which are the driving factors of the vascular grafts market?
The vascular graft market shows a tremendous growth owing to the increase in the number of minimally invasive procedures carried out by the technically advanced hospitals and healthcare systems.
Which region will lead the global vascular grafts market?
North America region will lead the global vascular grafts market over the forecast period 2022 to 2030.
  • Report Code:1758
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published

PROCEED TO BUY

   USD 4900
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample